Part of Thermo Fisher Scientific
Press Release
Frost & Sullivan Recognizes HyClone with Drug Discovery Product of the Year Award
|
San Diego-- (Business Wire)--Nov. 7, 2003-- Frost & Sullivan presents the Drug Discovery Product of the Year Award to the company that has demonstrated outstanding reliability, mission success, and excellence in technical efficiency and versatility. The product ranks higher in its market than similar competitive products and demonstrates continued superiority.
HyClone offers a broad line of The company, originally established to provide quality fetal bovine serum (FBS), is now a leading supplier and developer of serum-free media. Its innovative serum collection, filtration, and processing methods, as well as its "Metabolic Pathway Design" process of media formulation makes HyClone the first choice of researchers in the cell-culture market. The rapid expansion of cell culture for the research and production of promising therapeutics requires cell nutrients formulated for maximum cell growth and high production yields. Concerns about an increasingly tight supply of FBS and a move in the pharmaceutical industry to avoid animal-derived components whenever possible has resulted in a growing demand for serum-free media. While many media manufacturers offer serum-free solutions, HyClone draws upon its many years of experience in cell culture to develop media optimized for excellent results in a variety of popular cell-line platforms. "HyClone not only continues to provide innovative solutions for its FBS-dependent clients, but also presents them with a pathway to transition from animal-derived media to serum-free media," notes Isaac Meek, research analyst with Frost & Sullivan. "This sharing of knowledge and implementation of a customer-focused business model distinguishes HyClone from traditional life-science supply companies, greatly contributing to its leading position in the competitive cell-culture market." Its proficiency in media development and commitment to quality has provided HyClone with a loyal customer base that considers it more a research partner than merely a life-science supply company. Held in San Diego, Calif., the Frost & Sullivan banquet honored world-class companies for outstanding performance and achievements in the healthcare industry. An annual event, the banquet recognizes the quality and merit of these distinguished companies. About HyClone HyClone is a global manufacturer of serum, liquid and powdered media, process liquids, reagents, and single-use sterile liquid handling systems called BioProcess Containers(tm), which enable, among other things, bioprocessing in an animal-derived component-free environment. HyClone is a subsidiary of Fisher Scientific International Inc. (NYSE:FSH)
and part of the Perbio Science group. HyClone's headquarters are located
at 925 West 1800 South, Logan, UT, 84321, USA. Phone: About Frost & Sullivan Founded in 1961, Frost & Sullivan is recognized as a global leader in growth consulting. Frost & Sullivan Awards are presented to companies that demonstrate excellence in their industry, commending the diligence, commitment, and innovative business strategies required to advance in the global marketplace. Frost & Sullivan rigorously analyzes specific criteria to determine award recipients in a vast variety of market industries and landscapes. For further information, visit www.frost.com. Frost & Sullivan
|
||||
Copyright
© 2008 |
||||
| Thermo Fisher Scientific Inc. | ||||
| Learn more about Thermo Scientific Life Science Research Products | ||||
| RNAi
Technologies |
Nucleic
Acid Amplification |
Protein Research |
High
Content Screening |
For Europe |